Treatment of drooling with scopolamine in pediatric ICU: A case series report

Imagem de Miniatura
Arquivos
art_FRANCO_Treatment_of_drooling_with_scopolamine_in_pediatric_ICU_2018.PDF (363.23 KB)
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2018
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
CACITA, Nadia
FREUA, Karina Albuquerque
ORTEGA, Karem Lopez
PERES, Maria Paula Siqueira de Melo
Citação
SPECIAL CARE IN DENTISTRY, v.38, n.6, p.362-366, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Drooling is a condition that affects patients with difficulties in swallowing, being common in patients with mental, neurological or dysphagic deficiency. This condition is difficult to diagnose, as it is often confused with sialorrhea, and in many cases we have a hyposalivation scenario. Its diagnosis is subjective, which is why scales should be used for the standardization of the evaluation of the degree of drooling before and after the proposed treatment, as the Thomas-Stonell and Greenberg scale. It causes problems such as perioral infections, rashes, wet clothing, leading to social embarrassment, and may be a risk factor for respiratory infections caused by asymptomatic aspiration of saliva. It presents several treatments, among them the pharmacological one, that is dependent of the clinical picture of each patient that must be evaluated daily. This article refers to a series of reports of cases of children in mechanical ventilation by tracheostomy, hospitalized, with clinical diagnosis of drooling, and clinical improvement with the use of scopolamine by gastrostomy, without intercurrences during its use. The objective of this study is to show other professionals the importance of drooling management, and to expose the adopted behavior in the described cases, providing reduction of respiratory infections and improvement of the clinical and social complications resulting from drooling.
Palavras-chave
botulinum toxin, drooling, dysphagia, scopolamine
URI
https://observatorio.fm.usp.br/handle/OPI/30132
Referências
  1. BLASCO PA, 1992, DEV MED CHILD NEUROL, V34, P849
  2. Chaleat-Valayer E, 2016, EUR J PAEDIATR NEURO, V20, P524, DOI 10.1016/j.ejpn.2016.04.010
  3. Dodds W J, 1989, Dysphagia, V3, P171, DOI 10.1007/BF02407219
  4. Faria J, 2015, INT J PEDIATR OTORHI, V79, P2124, DOI 10.1016/j.ijporl.2015.09.029
  5. Hay N, 2011, INT J LANG COMM DIS, V46, P550, DOI 10.1111/j.1460-6984.2011.00010.x
  6. Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744
  7. Mato A, 2010, BRIT J CLIN PHARMACO, V69, P684, DOI 10.1111/j.1365-2125.2010.03659.x
  8. Montero AM, 2008, MED ORAL PATOL ORAL, V13, pE27
  9. Meningaud JP, 2006, ORAL SURG ORAL MED O, V101, P48, DOI 10.1016/j.tripleo.2005.08.018
  10. Miranda-Rius J, 2015, INT J MED SCI, V12, P811, DOI 10.7150/ijms.12912
  11. Dias BLS, 2017, ARQ NEURO-PSIQUIAT, V75, P282, DOI [10.1590/0004-282X20170033, 10.1590/0004-282x20170033]
  12. Scully C, 2009, J ORAL PATHOL MED, V38, P321, DOI 10.1111/j.1600-0714.2008.00727.x
  13. SIEGEL LK, 1991, DEV MED CHILD NEUROL, V33, P1013
  14. Sreebny LM, 2000, INT DENT J, V50, P140, DOI 10.1111/j.1875-595X.2000.tb00554.x
  15. Suskind DL, 2002, LARYNGOSCOPE, V112, P73, DOI 10.1097/00005537-200201000-00014
  16. Tahmassebi J F, 2003, Int J Paediatr Dent, V13, P106, DOI 10.1046/j.1365-263X.2003.00439.x
  17. TALMI YP, 1988, ANN OTO RHINOL LARYN, V97, P128, DOI 10.1177/000348948809700206
  18. Thomas-Stonell N, 1988, Dysphagia, V3, P73, DOI 10.1007/BF02412423
  19. Walshe M, 2012, COCHRANE DB SYST REV, V15
  20. Zeppetella G, 1999, J PAIN SYMPTOM MANAG, V17, P293, DOI 10.1016/S0885-3924(98)00143-2

Coleções
Artigos e Materiais de Revistas Científicas - HC/Outros